Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass.

J Clin Med · 2024 · PMC11122000 · PMID 38792487

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

From baseline to 12 h following the surgery, SEPP1 showed an increasing trend in all patients (69 [IQR 39–85] to 3263 [IQR 1886.2–5042.7] ng/mL; p for trend <0.0001).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.